The Effect of Serum Ferritin in irAE

NCT06702566 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Immune-related Adverse Event
Malignant Solid Tumors
Acute Leukemia
Serum Ferritin

Interventions

DRUG: PD-1 and PD-L1 inhibitor
DRUG: Targeted drugs
DRUG: chemotherapy drugs

Sponsor

Tianjin Medical University Cancer Institute and Hospital